Does Reduced Creatine Synthesis Protect against Statin Myopathy? Kevin D. Ballard, Paul D. Thompson Cell Metabolism Volume 18, Issue 6, Pages 773-774 (December 2013) DOI: 10.1016/j.cmet.2013.11.012 Copyright © 2013 Elsevier Inc. Terms and Conditions
Figure 1 Proposed Mechanism by which Reduced GATM Activity Reduces Statin Myopathy Risk Simvastatin reduced GATM transcriptional expression, and this effect was associated with a reduced incidence of statin myopathy (Mangravite et al., 2013). Reduced intramuscular Cr may protect against statin-induced myopathy. GATM, glycine amidinotransferase; CP, creatine phosphate; Cr, creatine. Cell Metabolism 2013 18, 773-774DOI: (10.1016/j.cmet.2013.11.012) Copyright © 2013 Elsevier Inc. Terms and Conditions